Choice PharmD provides pharmacist-led therapeutic guidance as a supplementary review to laboratory diagnostic results.
Our reports include detected findings, detailed pathogen explanations, and clinical interpretation of results to support providers in understanding PCR data and selecting appropriate therapy. Treatment considerations for detected pathogens emphasize antimicrobial stewardship, promoting effective therapies and responsible prescribing practices.
Choice PharmD reports are built to deliver clarity without disrupting existing laboratory workflows.
Each report includes:
Reports are designed to be read, understood, and used at the point of care.
Each Choice PharmD report is reviewed by a trained clinical pharmacist.
Pharmacists evaluate diagnostic findings using current clinical practice guidelines and published literature to support appropriate therapy selection. This human-led review helps simplify complex results, particularly in cases involving multiple pathogens or resistance genes. Treatment algorithms are utilized to increase efficiency and streamline reporting, however every result is reviewed by a live pharmacist.
Choice PharmD reports are provided as a supplementary component of the laboratory report.
They are integrated directly into the Laboratory Information System (LIS) and delivered alongside diagnostic results, allowing providers to review clinical interpretation and treatment considerations within their existing workflow.
Choice PharmD provides direct access to a trained, live pharmacist for provider support.
Each report includes a QR code that allows providers to connect with a pharmacist for clinical questions, including regimen clarification, allergy considerations, drug–drug interactions, and resistance interpretation. Providers may reach pharmacists via direct phone call or secure messaging.
Our goal is to serve as a reliable clinical resource for providers while supporting laboratories in delivering optimal patient care.
Choice PharmD offers monthly stewardship reporting to support laboratory insight and regulatory needs.
Lab stewardship reports provide a detailed breakdown of pathogen and resistance gene detection within a laboratory. Detection rates are compared to aggregate data across the Choice PharmD lab network, offering valuable context and trend analysis.
Facility stewardship reports include detailed tracking of pathogen and resistance gene detection at the facility level. These reports may include monitoring of notable pathogens, such as Clostridioides difficile and multidrug-resistant organisms, and can support reporting requirements for state health departments.
Sensitivity tables are available as an optional add-on to Choice PharmD PharmD reports.
These tables provide a comprehensive list of medications along with their general spectra of activity for detected organisms. Antimicrobial activity is based on general susceptibility data obtained from tertiary sources and is adjusted when clinically relevant resistance genes are detected.
Sensitivity tables are intended to support clinical understanding and are not a substitute for provider judgment.
Providers trust Choice PharmD for fast, evidence-based therapeutic guidance. Hear how our pharmacist-led reports help clinicians make confident decisions and improve patient outcomes.
